Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer

M. F. Sarosdy, P. F. Schellhammer, M. S. Soloway, N. J. Vogelzang, E. D. Crawford, J. Presti, G. W. Chodak, P. Mitchell, L. Porter

Research output: Contribution to journalArticle

55 Scopus citations

Fingerprint Dive into the research topics of 'Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences